108 related articles for article (PubMed ID: 30698275)
1. Differential gene expression analysis of sickle cell anemia in steady and crisis state.
Zanette DL; Santiago RP; Leite IPR; Santana SS; da Guarda C; Maffili VV; Ferreira JRD; Adanho CSA; Yahouedehou SCMA; Menezes IL; Goncalves MS
Ann Hum Genet; 2019 Sep; 83(5):310-317. PubMed ID: 30698275
[TBL] [Abstract][Full Text] [Related]
2. Association between Oxidative Stress, Genetic Factors, and Clinical Severity in Children with Sickle Cell Anemia.
Renoux C; Joly P; Faes C; Mury P; Eglenen B; Turkay M; Yavas G; Yalcin O; Bertrand Y; Garnier N; Cuzzubbo D; Gauthier A; Romana M; Möckesch B; Cannas G; Antoine-Jonville S; Pialoux V; Connes P
J Pediatr; 2018 Apr; 195():228-235. PubMed ID: 29449005
[TBL] [Abstract][Full Text] [Related]
3. Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.
Hierso R; Lemonne N; Villaescusa R; Lalanne-Mistrih ML; Charlot K; Etienne-Julan M; Tressières B; Lamarre Y; Tarer V; Garnier Y; Hernandez AA; Ferracci S; Connes P; Romana M; Hardy-Dessources MD
Br J Haematol; 2017 Mar; 176(5):805-813. PubMed ID: 27984639
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
[TBL] [Abstract][Full Text] [Related]
5. Significance of platelet activation in sickle cell anaemia.
Ibanga IA
Niger J Med; 2006; 15(2):148-50. PubMed ID: 16805172
[TBL] [Abstract][Full Text] [Related]
6. Circulating cell-free DNA in sickle cell disease: is it a potentially useful biomarker?
Al-Humood S; Zueriq R; Al-Faris L; Marouf R; Al-Mulla F
Arch Pathol Lab Med; 2014 May; 138(5):678-83. PubMed ID: 24786126
[TBL] [Abstract][Full Text] [Related]
7. Endothelial function in patients with sickle cell anemia during and after sickle cell crises.
Blum A; Yeganeh S; Peleg A; Vigder F; Kryuger K; Khatib A; Khazim K; Dauerman H
J Thromb Thrombolysis; 2005 Apr; 19(2):83-6. PubMed ID: 16052296
[TBL] [Abstract][Full Text] [Related]
8. Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis.
Papadimitriou CA; Travlou A; Kalos A; Douratsos D; Lali P
Acta Haematol; 1993; 89(4):180-3. PubMed ID: 8212998
[TBL] [Abstract][Full Text] [Related]
9. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
10. Circulating platelet aggregates in sickle cell disease patients with and without vaso-occlusion.
Mehta P; Mehta J
Stroke; 1979; 10(4):464-6. PubMed ID: 505486
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular changes in children with sickle cell crisis.
Onalo R; Cooper P; Cilliers A; Nnebe-Agumadu U
Cardiol Young; 2020 Feb; 30(2):162-170. PubMed ID: 31973786
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte counts in children with sickle cell disease. Comparative values in the steady state, vaso-occlusive crisis, and bacterial infection.
Buchanan GR; Glader BE
Am J Dis Child; 1978 Apr; 132(4):396-8. PubMed ID: 645659
[TBL] [Abstract][Full Text] [Related]
13. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.
Sarray S; Saleh LR; Lisa Saldanha F; Al-Habboubi HH; Mahdi N; Almawi WY
Cytokine; 2015 Mar; 72(1):43-7. PubMed ID: 25569375
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease.
Gonçalves MS; Queiroz IL; Cardoso SA; Zanetti A; Strapazoni AC; Adorno E; Albuquerque A; Sant'Ana A; dos Reis MG; Barral A; Barral Netto M
Braz J Med Biol Res; 2001 Oct; 34(10):1309-13. PubMed ID: 11593306
[TBL] [Abstract][Full Text] [Related]
15. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
Al Najjar S; Adam S; Ahmed N; Qari M
Ann Hematol; 2017 Jan; 96(1):141-146. PubMed ID: 27686084
[TBL] [Abstract][Full Text] [Related]
16. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease.
Nsiri B; Gritli N; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
Hematol Cell Ther; 1996 Jul; 38(3):279-84. PubMed ID: 8974793
[TBL] [Abstract][Full Text] [Related]
18. Elevated IL-8 levels during sickle cell crisis.
Duits AJ; Schnog JB; Lard LR; Saleh AW; Rojer RA
Eur J Haematol; 1998 Nov; 61(5):302-5. PubMed ID: 9855244
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
20. Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis.
Francis RB
Haemostasis; 1989; 19(2):105-11. PubMed ID: 2731776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
